BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37745147)

  • 1. The influence of growth hormone deficiency on bone health and metabolisms.
    Wydra A; Czajka-Oraniec I; Wydra J; Zgliczyński W
    Reumatologia; 2023; 61(4):239-247. PubMed ID: 37745147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M; Payer J
    Cas Lek Cesk; 2010; 149(5):211-6. PubMed ID: 20629339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
    Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.
    Kužma M; Binkley N; Bednárová A; Killinger Z; Vaňuga P; Payer J
    Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.
    Soliman A; De Sanctis V; Yassin M; Abdelrahman MO
    Indian J Endocrinol Metab; 2014 Jan; 18(1):32-8. PubMed ID: 24701427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
    Baroncelli GI; Bertelloni S; Sodini F; Saggese G
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
    Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
    Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of growth hormone on accretion of bone mass.
    Monson JP; Drake WM; Carroll PV; Weaver JU; Rodriguez-Arnao J; Savage MO
    Horm Res; 2002; 58 Suppl 1():52-6. PubMed ID: 12373015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of growth hormone on bone status in growth hormone-deficient adults.
    Kuzma M; Homerova Z; Dlesk A; Koller T; Killinger Z; Vanuga P; Lazurova I; Tomkova S; Payer J
    Bratisl Lek Listy; 2013; 114(12):689-95. PubMed ID: 24329506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H; Riedl M; Bernecker P; Clodi M; Kainberger F; Kaider A; Woloszczuk W; Luger A
    Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.